Osaühing EbeKar
Osaühing EbeKar is a OÜ based in Haabneeme alevik, registry code 10078865, status: active. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €80 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 80 €above 2% of companiesindustry median 234 187 € · companies in the industry: 12
- Revenue · 2025 1 117 €above 24% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 -548.9 %above 2% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 80 | — | — | — |
| Q2 2026 | 160 | 21 | — | — |
| Q1 2026 | 239 | 51 | — | — |
| Q4 2025 | 319 | 23 | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | 479 | 55 | — | — |
| Q1 2025 | 319 | 26 | — | — |
| Q4 2024 | 319 | — | — | — |
| Q3 2024 | 196 | — | — | — |
| Q2 2024 | 443 | 69 | — | — |
| Q1 2024 | 200 | — | — | — |
| Q4 2023 | 479 | 33 | — | — |
| Q3 2023 | 18 713 | 3 640 | — | — |
| Q2 2023 | — | — | — | — |
| Q1 2023 | 718 | 79 | — | — |
| Q4 2022 | 615 | 39 | — | — |
| Q3 2022 | 269 | 2 | — | — |
| Q2 2022 | 355 | 20 | — | — |
| Q1 2022 | 3 194 | 307 | — | — |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 1 117 | -6 131 | 0 | 22 219 | 22 153 | 0 |
| 2024 | 1 118 | -2 514 | 0 | 28 417 | 28 284 | 0 |
| 2023 | 1 311 | 6 430 | 0 | 30 845 | 30 798 | 0 |
| 2022 | 4 897 | -3 293 | 0 | 24 491 | 24 369 | 0 |
| 2021 | 1 501 | -108 | 0 | 28 028 | 27 662 | 0 |
| 2020 | 4 813 | 1 612 | 0 | 27 839 | 27 770 | 0 |
| 2019 | 4 987 | 1 969 | 0 | 26 240 | 26 158 | 0 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 0 |
| 2015 | — | — | — | — | — | 1 |
| 2014 | — | — | — | — | — | 1 |
| 2013 | — | — | — | — | — | 1 |
| 2012 | — | — | — | — | — | 1 |
| 2011 | — | — | — | — | — | 1 |
| 2010 | — | — | — | — | — | 1 |
| 2009 | — | — | — | — | — | 1 |
| 2008 | — | — | — | — | — | 3 |
| 2007 | — | — | — | — | — | 1 |
| 2006 | — | — | — | — | — | 1 |
| 2005 | — | — | — | — | — | 1 |
| 2003 | — | — | — | — | — | 2 |
| 2002 | — | — | — | — | — | 2 |
| 2001 | — | — | — | — | — | 2 |
| 2000 | — | — | — | — | — | 2 |
| 1999 | — | — | — | — | — | 2 |
| 1998 | — | — | — | — | — | 2 |
| 1997 | — | — | — | — | — | 3 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 13 Mar 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 11 Feb 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 2 Aug 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 4 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 16 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 23 Feb 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 16 May 2020 | Company’s own | e-Äriregister |
Board
- Rein EbenekBoard member · since 16 Sep 2024
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Rein EbenekNatural person · 6 372 €
- Reijo KarppinenNatural person · 19 €
Beneficial owners
- Rein EbenekDirect ownership · since 10 Sep 2024
Founders and other persons
No other persons.
Activities (EMTAK)
- 21201Manufacture of pharmaceutical preparations Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10005083 / 13 16 Sep 2024 |
Amendment entry | In force 16 Sep 2024 |
||
| Ä 10005083 / 12 1 Aug 2024 |
Amendment entry | In force 1 Aug 2024 |
||
| Ä 10005083 / M5 6 Jul 2024 |
Warning of deletion from the register: annual report not filed | 9 Oct 2024 | Deficiencies eliminated 3 Aug 2024 |
|
| Ä 10005083 / 11 28 Jun 2024 |
Amendment entry | In force 28 Jun 2024 |
||
| Ä 10005083 / 10 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 10005083 / 9 16 Jan 2018 |
Amendment entry | In force 16 Jan 2018 |
||
| Ä 10005083 / 8 7 Nov 2017 |
Amendment entry | In force 7 Nov 2017 |
||
| Ä 10005083 / 7 26 Apr 2012 |
Amendment entry | In force 26 Apr 2012 |
||
| Ä 10005083 / 6 26 Apr 2012 |
Entry refused: deficiencies not eliminated | In force 16 May 2012 |
||
| Ä 10005083 / M4 26 Jan 2012 |
Ruling to eliminate deficiencies | In force 26 Jan 2012 |
||
| Ä 5083 / 5 3 Dec 2008 |
Deletion of activities from the registry card | In force 15 Dec 2008 |
||
| Ä 5083 / 4 20 May 2004 |
Amendment entry | In force | ||
| Ä 5083 / 3 17 Sep 2003 |
Negative entry decision | In force | ||
| Ä 5083 / M3 4 Mar 2003 |
Ruling to eliminate deficiencies (to be served) | 6 Jun 2003 | In force | |
| Ä 5083 / M2 31 May 2002 |
Ruling to eliminate deficiencies (to be served) | 8 Aug 2002 | In force |
Sources: e-Äriregister and EMTA. Data updated 30 Oct 2026. Open at the source ↗ · Report an error in the data